Mylan Labs

Medicines Co. prevails in patent challenge from Mylan
Medicines Co. prevails in patent challenge from Mylan
Seeking Alpha
Medicines Company
patents
Mylan Labs
Angiomax
Flag link:
The Mylan-Abbott Inversion Deal is Still on… but With Some Changes
The Mylan-Abbott Inversion Deal is Still on… but With Some Changes
WSJ Pharmalot
Mylan Labs
Abbott Labs
M&A
tax inversions
Flag link:
Mylan Faces Investor Pressure Over a Drug to be Used for Executions
Mylan Faces Investor Pressure Over a Drug to be Used for Executions
WSJ Pharmalot
Mylan Labs
execution drugs
Flag link:
Is Teva knocking on Mylan's door? With inversion deal at risk, maybe
Is Teva knocking on Mylan's door? With inversion deal at risk, maybe
Fierce Pharma
Teva Pharmaceutical
Mylan Labs
tax inversions
M&A
Flag link:
Mylan Surges on Improved Q3 and Full-Year Earnings Outlook
Mylan Surges on Improved Q3 and Full-Year Earnings Outlook
Yahoo/Zacks.com
earnings
Mylan Labs
Flag link:
Tax-deal crackdown's victims, say analysts? Mylan and Abbott, not Pfizer and AZ
Tax-deal crackdown's victims, say analysts? Mylan and Abbott, not Pfizer and AZ
Fierce Pharma
Mylan Labs
Pfizer
AstraZeneca
Shire
AbbVie
tax inversions
Abbott Labs
Flag link:
Gilead signs pact with 7 firms for cheap copies of hepatitis C drug
Gilead signs pact with 7 firms for cheap copies of hepatitis C drug
Yahoo/Reuters
Gilead Sciences
Sovaldi
generics
hepatitis C
Cipla
Ranbaxy
Cadila
Mylan Labs
Strides Arcolab
Hetero Drugs
Sequent Scientific
Flag link:
Mylan to Acquire Arixtra Rights for $225M
Mylan to Acquire Arixtra Rights for $225M
Drug Discovery and Development
Mylan Labs
Arixtra
DVT
deep vein thrombosis
Aspen Global
Flag link:
Wockhardt Comeback Sets Up Drugmaker as Target: Real M&A
Wockhardt Comeback Sets Up Drugmaker as Target: Real M&A
Bloomberg
Wockhardt
M&A
India
Lupin
Mylan Labs
Actavis
Teva Pharmaceutical
Flag link:
Mylan, private equity, Indian pharmas to compete for cast-off GSK brands
Mylan, private equity, Indian pharmas to compete for cast-off GSK brands
Fierce Pharma
Mylan Labs
India
GSK
M&A
Paxil
Malarone
Lovaza
Flag link:
Mylan Posts Lower Q2 Earnings, Narrows Full-Year Outlook
Mylan Posts Lower Q2 Earnings, Narrows Full-Year Outlook
Benzinga
Mylan Labs
earnings
Flag link:
Teva's Nuvigil Patent Infringement Lawsuits Resolved
Teva's Nuvigil Patent Infringement Lawsuits Resolved
Yahoo/Zacks.com
NUVIGIL
patents
Teva Pharmaceuticals
Sandoz
Apotex
Mylan Labs
Actavis
Lupin
Flag link:
Teva Loses Suit Against FDA Over Generic of Copaxone
Teva Loses Suit Against FDA Over Generic of Copaxone
Bloomberg
Teva
FDA
generics
Copaxone
Mylan Labs
Novartis
Sandoz
multiple sclerosis
Flag link:
Is Abbott Laboratories Headed for a Breakup?
Is Abbott Laboratories Headed for a Breakup?
Motley Fool
Abbott Labs
M&A
generics
Mylan Labs
Teva Pharmaceuticals
Flag link:
Meda CEO says company could double size in two years
Meda CEO says company could double size in two years
Reuters
Meda
Mylan Labs
M&A
Flag link:

Pages